ELI LILLY & Co

LLY 10-Q · Q2 2025
API behind this page

LLY Q2 2025 request

Playground key active
Request URL /api/financials?ticker=LLY&year=2025&quarter=2
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q2 2025 Q2 2024 YoY
Revenue 15,557.7 11,302.8 +37.6%
Show Product Lines breakouts
Cardiometabolic Health 11,342.9 7,514.6 +50.9%
Cardiometabolic Health · Non Us 2,979.5 1,798.5 +65.7%
Cardiometabolic Health · US 8,363.4 5,716.1 +46.3%
Collaboration and Other Revenue [Member] 831.7 947.9 -12.3%
Immunology 1,255.6 1,082.4 +16.0%
Immunology · Non Us 554.6 482.6 +14.9%
Immunology · US 700.9 599.8 +16.9%
Jardiance 690 769.6 -10.3%
Jardiance · Non Us 307.8 340.7 -9.7%
Jardiance · US 382.2 428.9 -10.9%
Mounjaro 5,198.9 3,090.8 +68.2%
Mounjaro · Non Us 1,897.1 677.2 +180.1%
Mounjaro · US 3,301.8 2,413.7 +36.8%
Neuroscience 344 339.5 +1.3%
Neuroscience · Non Us 96.1 147.6 -34.9%
Neuroscience · US 247.9 191.9 +29.2%
Oncology 2,413.6 2,158.7 +11.8%
Oncology · Non Us 994.3 883.5 +12.5%
Oncology · US 1,419.3 1,275.2 +11.3%
Other 201.5 207.6 -2.9%
Other cardiometabolic health 980.4 1,165.4 -15.9%
Other cardiometabolic health · Non Us 424.7 411.7 +3.2%
Other cardiometabolic health · US 555.7 753.6 -26.3%
Other immunology 408 257.7 +58.3%
Other immunology · Non Us 255.8 197.3 +29.7%
Other immunology · US 152.1 60.4 +151.8%
Other oncology 924.3 826.8 +11.8%
Other oncology · Non Us 434 413 +5.1%
Other oncology · US 490.3 413.8 +18.5%
Other · Non Us 118.9 155.4 -23.5%
Other · US 82.7 52.2 +58.4%
Product 14,726 10,354.9 +42.2%
Taltz 847.6 824.7 +2.8%
Taltz · Non Us 298.8 285.3 +4.7%
Taltz · US 548.8 539.4 +1.7%
Trulicity 1,092.2 1,245.6 -12.3%
Trulicity · Non Us 348.4 368.9 -5.6%
Trulicity · US 743.8 876.7 -15.2%
Verzenio 1,489.3 1,331.9 +11.8%
Verzenio · Non Us 560.3 470.5 +19.1%
Verzenio · US 929 861.4 +7.8%
Zepbound 3,381.4 1,243.2 +172.0%
Zepbound · Non Us 1.5 — —
Zepbound · US 3,379.9 1,243.2 +171.9%
Show Business Segments breakouts
Reportable Segment 15,557.7 11,302.8 +37.6%
Show Geography breakouts
CN 465.9 395.1 +17.9%
Europe 2,574.4 1,403.7 +83.4%
JP 521 462.7 +12.6%
Non Us 4,743.4 3,467.5 +36.8%
Rest of world 1,182.1 1,206.1 -2.0%
US 10,814.2 7,835.2 +38.0%
Cost of Revenue 2,447.8 2,170.2 +12.8%
Show Business Segments breakouts
Reportable Segment 2,447.8 2,170.2 +12.8%
Research And Development Expense Excluding Acquired In Process Cost 3,336.1 2,711.2 +23.0%
Show Product Lines breakouts
Early-stage · Reportable Segment 1,156 1,025.3 +12.7%
Late-stage · Reportable Segment 2,180.1 1,685.9 +29.3%
Selling, General & Administrative 2,753 2,117.3 +30.0%
Show Business Segments breakouts
Reportable Segment 2,753 2,117.3 +30.0%
Research And Development Asset Acquired Other Than Through Business Combination Written Off 153.8 154.3 -0.3%
Show Business Segments breakouts
Reportable Segment 153.8 154.3 -0.3%
Non-Operating Income (Expense) 90.6 197.6 -54.1%
Cost Of Sales Operating Expenses And Other Net 8,781.3 7,785.6 +12.8%
Income Before Taxes 6,776.4 3,517.2 +92.7%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment · Reclassification Out Of Accumulated Other Comprehensive Income 21.2 30.2 -29.8%
Income Tax Expense (Benefit) 1,115.9 550.2 +102.8%
Show Business Segments breakouts
Reportable Segment 1,115.9 550.2 +102.8%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment · Reclassification Out Of Accumulated Other Comprehensive Income 4.5 6.3 -28.6%
Net Income 5,660.5 2,967 +90.8%
Show Business Segments breakouts
Reportable Segment 5,660.5 2,967 +90.8%
EPS (Basic) 6.3 3.29 +91.5%
EPS (Diluted) 6.29 3.28 +91.8%
Wtd Avg Shares (Basic) 897.9 900.9 -0.3%
Wtd Avg Shares (Diluted) 899.8 904.2 -0.5%
Interest Expense 249 183.6 +35.6%
Show Business Segments breakouts
Reportable Segment 249 183.6 +35.6%
Interest Income 40 37.3 +7.2%
Show Business Segments breakouts
Reportable Segment 40 37.3 +7.2%
Other Non-Operating Income (Expense) -101 -7.8 -1194.9%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment Net Prior Service Cost Credit · Reclassification Out Of Accumulated Other Comprehensive Income 0.4 -0.9 +144.4%
Accumulated Defined Benefit Plans Adjustment Net Unamortized Gain Loss · Reclassification Out Of Accumulated Other Comprehensive Income 20.8 31.1 -33.1%
Other, net of tax · Reclassification Out Of Accumulated Other Comprehensive Income 5.5 0.8 +587.5%
Net Income (Q) — — —
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment · Reclassification Out Of Accumulated Other Comprehensive Income 16.7 23.9 -30.1%
Noncontrolling Interest 18.7 -9.9 +288.9%
Retained Earnings 5,660.5 2,967 +90.8%
Show Reclassification Out Of Accumulated Other Comprehensive Income breakouts
Reclassification Out Of Accumulated Other Comprehensive Income 22.2 24.7 -10.1%
Comprehensive Income 5,719.1 2,888 +98.0%
Other Comprehensive Income 58.6 -79 +174.2%
Show Equity Components breakouts
Accumulated Other Comprehensive Income 58.6 -79 +174.2%
Income Loss From Equity Method Investments (Q) — — —
Show Business Segments breakouts
Reportable Segment -16 25.9 -161.8%

Balance Sheet

Balance Sheet
Metric Q2 2025 Q2 2024 YoY
Current Assets
Cash & Cash Equivalents 3,375.9 3,223.6 +4.7%
Short-Term Investments 170.1 140.4 +21.2%
Accounts Receivable 14,170.4 11,027.9 +28.5%
Other Receivables Net Current 3,035.2 2,051.1 +48.0%
Inventory 11,013.8 6,481.5 +69.9%
Prepaid Expense Current 18,019.8 7,137.6 +152.5%
Other Assets Current 68.8 142.2 -51.6%
Total Current Assets 49,854 30,204.3 +65.1%
Non-Current Assets
Long Term Investments 3,207.4 2,877.6 +11.5%
Show Fair Value By Measurement Basis breakouts
Carrying Reported Amount Fair Value Disclosure 3,207.4 2,877.6 +11.5%
Goodwill 5,770.5 — —
Deferred Tax Assets 9,427.4 6,655.3 +41.7%
Property, Plant & Equipment 20,529.7 14,829.4 +38.4%
Other Non-Current Assets 6,225.3 4,903.9 +26.9%
Total Assets 100,922.6 — —
Show Business Segments breakouts
Reportable Segment 100,922.6 — —
Other Assets
Intangible Assets Net Excluding Goodwill 5,908.3 6,636.1 -11.0%
Current Liabilities
Debt Current 5,723.7 5,161.6 +10.9%
Accounts Payable 4,075.7 2,924.8 +39.3%
Employee Related Liabilities Current 1,303 1,168.3 +11.5%
Sales Rebates And Discounts 14,537.4 12,446.8 +16.8%
Dividends Payable Current 1,345.2 1,170.5 +14.9%
Taxes Payable Current 6,958 — —
Other Liabilities Current 5,076.9 4,249.2 +19.5%
Total Current Liabilities 39,019.9 27,121.2 +43.9%
Commercial Paper (Q) — — —
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level2 · Estimate Of Fair Value Fair Value Disclosure 4,083.6 4,375.2 -6.7%
Show Fair Value By Measurement Basis breakouts
Carrying Reported Amount Fair Value Disclosure · Commercial Paper 4,091.7 4,384.7 -6.7%
Estimate Of Fair Value Fair Value Disclosure · Commercial Paper 4,083.6 4,375.2 -6.7%
Non-Current Liabilities
Long-Term Debt 34,180.1 23,730.4 +44.0%
Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent 1,344.5 1,420.4 -5.3%
Accrued Income Taxes Noncurrent 5,684.3 3,496.6 +62.6%
Other Non-Current Liabilities 2,344.7 2,470.7 -5.1%
Liabilities Noncurrent 43,553.6 31,118.1 +40.0%
Long-Term Debt (Q) — — —
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level2 · Estimate Of Fair Value Fair Value Disclosure 32,907.3 21,709.9 +51.6%
Show Fair Value By Measurement Basis breakouts
Carrying Reported Amount Fair Value Disclosure 35,812 24,507.3 +46.1%
Estimate Of Fair Value Fair Value Disclosure 32,907.3 21,709.9 +51.6%
Show Long-Term Debt Type breakouts
Foreign Currency Denominated Debt 6.8 6.86 -0.9%
Other Liabilities
Minority Interest 76.2 73.5 +3.7%
Stockholders' Equity
Common Stock 592 594.2 -0.4%
Additional Paid In Capital Common Stock 7,089.3 7,214.2 -1.7%
Retained Earnings 17,376.2 13,178 +31.9%
Common Stock Shares Held In Employee Trust -3,013.2 -3,013.2 0.0%
Accumulated Other Comprehensive Income -3,716 -4,378.5 +15.1%
Treasury Stock Common Value -55.4 -32.7 -69.4%
Total Stockholders' Equity 18,272.9 13,562 +34.7%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 18,349.1 — —
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment -2,193.4 -2,633.6 +16.7%
Accumulated Gain Loss Net Cash Flow Hedge Parent 256.5 289.3 -11.3%
Accumulated Net Unrealized Investment Gain Loss -21.3 -32.6 +34.7%
Accumulated Other Comprehensive Income -3,716 -4,378.5 +15.1%
Accumulated Translation Adjustment -1,757.8 -2,001.6 +12.2%
Additional Paid In Capital 7,089.3 7,214.2 -1.7%
Common Stock 592 594.2 -0.4%
Noncontrolling Interest 76.2 73.5 +3.7%
Retained Earnings 17,376.2 13,178 +31.9%
Treasury Stock Common -55.4 -32.7 -69.4%
Trust For Benefit Of Employees -3,013.2 -3,013.2 0.0%
Total Liabilities & Equity 100,922.6 71,874.8 +40.4%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q2 2025 YTD Q2 2024 YoY
Operating Activities
Depreciation & Amortization 941.3 815 +15.5%
Show Business Segments breakouts
Reportable Segment 941.3 815 +15.5%
Increase Decrease In Deferred Income Taxes -1,460.3 -1,286.6 -13.5%
Stock-Based Compensation 338.8 370.5 -8.6%
Gain Loss On Investments 35.3 142.2 -75.2%
Increase Decrease In Other Operating Capital Net -5,627.1 -3,150.3 -78.6%
Other Operating Activities Cash Flow Statement 379.2 266.7 +42.2%
Net Cash from Operations 4,752.5 2,632.2 +80.6%
Investing Activities
Payments To Acquire Other Property Plant And Equipment -3,206.6 -2,211.1 -45.0%
Proceeds From Sale And Maturity Of Other Investments 275.9 250.1 +10.3%
Payments To Acquire Other Investments -367.9 -250.1 -47.1%
Payments To Acquire In Process Research And Development -1,863.8 -274.5 -579.0%
Other Investing Activities -24.8 57 -143.5%
Net Cash from Investing -5,187.2 -3,376.3 -53.6%
Financing Activities
Payments Of Dividends -2,693.3 -2,341.6 -15.0%
Proceeds From Repayments Of Short Term Debt -245.9 -1,804.7 +86.4%
Proceeds From Issuance Of Long Term Debt 6,461 6,452.5 +0.1%
Repayments Of Long Term Debt -778.1 -664.2 -17.1%
Share Repurchases -1,892.2 — —
Proceeds From Payments For Other Financing Activities -716.7 -397.8 -80.2%
Net Cash from Financing 134.8 1,244.2 -89.2%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 407.4 -95.1 +528.4%
Net Change in Cash 107.5 405 -73.5%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 3,375.9 3,223.6 +4.7%

Values in millions USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key